Quotes Spyre Therapeutics, Inc. Deutsche Boerse AG
Stocks
3920
US00773J2024
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
02:09:06 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 74.00 EUR | 0.00% |
|
-6.33% | +170.07% |
| 09-04 | Spyre Therapeutics Insider Sold Shares Worth $2,480,529, According to a Recent SEC Filing | MT |
| 09-04 | Spyre Therapeutics Insider Sold Shares Worth $1,309,410, According to a Recent SEC Filing | MT |
Stock exchange
Quotes 5-day view: Spyre Therapeutics, Inc.
Delayed Quote Deutsche Boerse AG
| 2026-08-31 | 2026-09-01 | 2026-09-02 | 2026-09-03 | 2026-09-04 | |
|---|---|---|---|---|---|
| Last | €75.50 | €76.00 | €75.50 | €74.00 | €74.00 |
| Volume | 23 | 0 | 0 | 0 | 0 |
| Change | -4.43% | +0.66% | -0.66% | -1.99% | 0.00% |
| Opening | €76.50 | €76.00 | €75.50 | €74.00 | €74.00 |
| High | €76.50 | €76.00 | €75.50 | €74.00 | €74.00 |
| Low | €75.50 | €76.00 | €75.50 | €74.00 | €74.00 |
Performance
| 1 week | -6.33% | ||
| Current month | -1.99% | ||
| 1 month | -18.68% | ||
| 3 months | +10.45% | ||
| 6 months | +111.43% | ||
| Current year | +170.07% | ||
| 1 year | +413.89% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
7,845,701,342
Market Cap (USD)
7,845,701,342
Net sales (USD)
0
Number of employees
125
Sales / Employee (USD)
0
Free-Float
89.36 %
Free-Float capitalization (EUR)
8,147,872,334
Free-Float capitalization (USD)
7,011,244,144
Average Daily Capital Traded
0%
Indicators
Moving average 5 days
75
Moving average 20 days
85.68
Moving average 50 days
84.56
Moving average 100 days
74.75
Price spread / (MMA5)
+1.35%
Price spread / (MMA20)
+15.78%
Price spread / (MMA50)
+14.27%
Price spread / (MMA100)
+1.01%
RSI 9 days
23.28
RSI 14 days
32.29
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -6.33% | +413.89% | - | 7.85B | |
| -1.79% | -2.27% | +43.23% | +88.96% | 67.98B | |
| -2.06% | -0.18% | +39.67% | +86.44% | 64.94B | |
| -0.31% | +6.54% | -12.96% | +378.92% | 27.58B | |
| +0.86% | +1.65% | -7.74% | -14.95% | 26.06B | |
| -3.00% | -2.90% | +33.13% | +12.54% | 25.74B | |
| -1.46% | +0.42% | +23.61% | -18.61% | 20.09B | |
| -2.96% | -15.21% | +216.20% | +368.10% | 17.16B | |
| -1.49% | -4.88% | -6.60% | +531.89% | 14.92B | |
| -0.20% | +8.37% | +55.78% | +164.98% | 14.62B | |
| Average | -1.24% | +0.26% | +79.82% | +177.58% | 28.69B | |
| Weighted average by Cap. | -1.48% | +0.18% | +48.64% | +137.35% |
Historical Quotes: Spyre Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 74 |  | 76.5 |
| 1 month | 74 | | 92.5 |
| Current year | 25.4 | | 92.5 |
| 1 year | 12.3 | | 92.5 |
| 3 years | 10.3 | | 92.5 |
| 5 years | 10.3 | | 92.5 |
| 10 years | 10.3 | | 92.5 |
Monthly variations
Annual variations
| 2026 | +170.07% | ||
| 2025 | +22.32% | ||
| 2024 | -35.07% |
- Stock Market
- Stocks
- SYRE Stock
- 3920 Stock
- Quotes Spyre Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
